CStone Pharmaceuticals Eulerpool Ziņas

CStone Pharmaceuticals Eulerpool News

CStone Pharmaceuticals Akciju Ziņas

CStone Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās CStone Pharmaceuticals ziņas mēs apkopojam šeit.

• 30. septembris ·

  Yahoo
  High Growth Tech Stocks In Hong Kong To Watch This September 2024
• 2. septembris ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring SUNeVision Holdings And Two Others
• 23. augusts ·

  Yahoo
  CStone Reports 2024 Interim Results and Recent Corporate Updates
• 26. jūlijs ·

  Yahoo
  CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
• 2. jūnijs ·

  SeekingAlpha
  Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
• 2. jūnijs ·

  Yahoo
  CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
• 26. maijs ·

  SeekingAlpha
  Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
• 24. maijs ·

  Yahoo
  CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website
• 27. marts ·

  Yahoo
  CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
• 15. marts ·

  Yahoo
  CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer